Committed to Curing Canine Cancer
Morris Animal Foundation’s Canine Cancer Campaign ran from 2007 to 2012. This was an awareness and fundraising initiative to give scientists genetic tools to study cancer, to help researchers test treatments and determine ways to prevent cancer, and to train new canine cancer researchers.
Thanks to the support of dog lovers throughout the country, Morris Animal Foundation provided more than $5 million in funds for more than 45 canine cancer studies during the five-year period. Many of these studies are still under way and already completed studies have helped create inroads for dogs to beat this disease.
Some campaign successes
- Worked with multiple partners to establish a tumor tissue bank that houses samples of the most common canine cancers, which will help scientists study cancer and potential treatments
- Funded two programs to train scientists to head research programs that will lead to new discoveries in the field of cancer for companion animals
- Discovered genetic information that could lead to a prognostic lymphoma test and identified inherited deficiencies that may contribute to the development of lymphoma in Golden Retrievers
- Developed dosing calculations that will help provide more effective and safer chemotherapy dosing, determined more effective ways to administer chemotherapy and found evidence of how to overcome chemotherapy resistance
- Identified a promising inhibitor that may help kill bone cancer cells and a drug with potential for shrinking soft-tissue sarcomas
- Raised awareness of canine cancer through the K9 Cancer Walk Program, which hosted 13 walks that involved more than 5,000 dog lovers and raised more than half a million dollars for canine cancer research
Over the past 10 years, more than one-third of all canine health studies have focused on canine cancer.
Also, Morris Animal Foundation has pledged nearly $5.5 million for studies currently under way, and at the Foundation’s annual meeting in June 2012, more than 40 percent of the new canine studies approved for funding focus on cancer. Support for these efforts is still greatly needed—donate here.